Witnesses Keith Chantler, Director of Innovation, Manchester University NHS Foundation Trust, Dame Julie Moore, Chief Executive, University Hospitals Birmingham NHS Foundation Trust and Professor Bryan Williams, Director of R&D, University College London Hospitals
Witnesses Dr Ian Hudson, Chief Executive, Medicines and Healthcare Regulatory Agency (MHRA) and Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence (NICE)
Witnesses Dave Allen, Senior Vice President, Respiratory Disease R&D, GSK and Menelas Pangalos, Executive Vice President of Innovative Medicines and Early Development (IMED) Biotech Unit, AstraZeneca
Witnesses Professor Chris Lowe OBE, Emeritus Professor and Director of the Cambridge Academy of Pharmaceutical Sciences, Cambridge University, Professor John Atherton, Pro Vice-Chancellor and Dean of the School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Professor David Price, Vice-Provost, University College London and Professor James Stirling CBE, Provost, Imperial College London
Witnesses Dr Annette Bramley, Head of Healthcare Technologies, Engineering and Physical Sciences Research Council (EPSRC), Sir John Savill, Chief Executive, Medical Research Council (MRC), Louise Wren, Policy Adviser, Wellcome Trust and Sir Harpal Kumar, Chief Executive Officer, Cancer Research UK